Share-based Compensation (Tables)

9 Months Ended

Mar. 31, 2023

Share-based Compensation

Summary of stock option award activity

						Weighted
		Weighted-				Average
		Average		Aggregate		Remaining
		Exercise		Intrinsic		Contractual
(In thousands, except for weighted average price and life data)	Awards	Price		Value		Life (yrs.)
Outstanding at June 30, 2022	234	$	35.76	$	—	6.5
Forfeited, expired or repurchased	(6)	$	32.54
Outstanding at March 31, 2023	228	$	35.85	$	—	5.9
Vested and expected to vest at March 31, 2023	228	$	35.85	$	—	5.9
Exercisable at March 31, 2023	177	$	38.92	$	—	5.6

Summary of non-vested restricted stock awards

		Weighted
		Average Grant-date		Aggregate
(In thousands, except for weighted average price data)	Awards	Fair Value		Intrinsic Value
Non-vested at June 30, 2022	339	$	21.19
Vested	(139)		21.87	$	320
Forfeited	(12)		19.60
Non-vested at March 31, 2023	188	$	20.70

Schedule of allocation of share-based compensation

	Three Months Ended				Nine Months Ended
	March 31,				March 31,
(In thousands)	2023		2022		2023		2022
Selling, general and administrative expenses	$	1,367	$	1,501	$	4,203	$	6,313
Research and development expenses		15		29		71		151
Cost of sales		93		169		312		562
Total	$	1,475	$	1,699	$	4,586	$	7,026
Tax benefit at statutory rate	$	332	$	382	$	1,032	$	1,581